Thus, based on the nomogram, each patient's risk for LNM can be accurately calculated according to the six variables, which were tumor size, CEA level, imaging density, pathological type of NSCLC (adenocarcinoma or non-adenocarcinoma), lymphovascular invasion and pleural invasion. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.